PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-90.13%
Revenue decline while CRVO shows 0.00% growth. Joel Greenblatt would examine competitive position erosion.
No Data
No Data available this quarter, please select a different quarter.
-148.93%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-595.65%
Margin decline while CRVO shows 0.00% expansion. Joel Greenblatt would examine competitive position.
15.04%
R&D growth while CRVO reduces spending. John Neff would investigate strategic advantage.
33.15%
G&A change of 33.15% while CRVO maintains overhead. Bruce Berkowitz would investigate efficiency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.43%
Operating expenses growth while CRVO reduces costs. John Neff would investigate differences.
20.43%
Total costs growth while CRVO reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
3.01%
D&A growth less than half of CRVO's 36.72%. David Dodd would verify if efficiency is sustainable.
-24.86%
EBITDA decline while CRVO shows 72.75% growth. Joel Greenblatt would examine position.
-1164.87%
EBITDA margin decline while CRVO shows 0.00% growth. Joel Greenblatt would examine position.
-24.41%
Operating income decline while CRVO shows 14.54% growth. Joel Greenblatt would examine position.
-1160.31%
Operating margin decline while CRVO shows 0.00% growth. Joel Greenblatt would examine position.
-17.39%
Other expenses reduction while CRVO shows 99.90% growth. Joel Greenblatt would examine advantage.
-24.71%
Pre-tax income decline while CRVO shows 72.52% growth. Joel Greenblatt would examine position.
-1163.35%
Pre-tax margin decline while CRVO shows 0.00% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-24.71%
Net income decline while CRVO shows 71.52% growth. Joel Greenblatt would examine position.
-1163.35%
Net margin decline while CRVO shows 0.00% growth. Joel Greenblatt would examine position.
-23.33%
EPS decline while CRVO shows 71.49% growth. Joel Greenblatt would examine position.
-23.33%
Diluted EPS decline while CRVO shows 71.49% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.